» Articles » PMID: 16439542

Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-inducible Coexpression of a Short Hairpin RNA and Protein

Overview
Journal J Virol
Date 2006 Jan 28
PMID 16439542
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrate a novel approach for coexpression of a short hairpin RNA (shRNA) with an open reading frame which exploits transcriptional read-through of a minimal polyadenylation signal from a Pol II promoter. We first observed efficient inducible expression of enhanced green fluorescent protein along with an anti-rev shRNA. We took advantage of this observation to test coexpression of the transdominant negative mutant (humanized) of human immunodeficiency type 1 (HIV-1) Rev (huRevM10) along with an anti-rev shRNA via an HIV-1-inducible fusion promoter. The coexpression of the shRNA and transdominant protein resulted in potent, long-term inhibition of HIV-1 gene expression and suppression of shRNA-resistant mutants. This dual expression system has broad-based potential for other shRNA applications, such as cases where simultaneous knockdown of mutant and wild-type transcripts must be accompanied by replacement of the wild-type protein.

Citing Articles

A conditional RNA Pol II mono-promoter drives HIV-inducible, CRISPR-mediated cyclin T1 suppression and HIV inhibition.

Chinnapaiyan S, Santiago M, Panda K, Rahman M, Alluin J, Rossi J Mol Ther Nucleic Acids. 2023; 32:553-565.

PMID: 37215150 PMC: 10192333. DOI: 10.1016/j.omtn.2023.04.011.


A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition.

Behmardi A, Farazmandfar T Drug Deliv Transl Res. 2022; 12(10):2561-2568.

PMID: 35098492 DOI: 10.1007/s13346-021-01109-y.


CRISPR-Cas13a Inhibits HIV-1 Infection.

Yin L, Zhao F, Sun H, Wang Z, Huang Y, Zhu W Mol Ther Nucleic Acids. 2020; 21:147-155.

PMID: 32585623 PMC: 7321785. DOI: 10.1016/j.omtn.2020.05.030.


RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs.

Bajan S, Hutvagner G Cells. 2020; 9(1).

PMID: 31936122 PMC: 7016530. DOI: 10.3390/cells9010137.


Aptamers in HIV research diagnosis and therapy.

Bala J, Chinnapaiyan S, Kumar Dutta R, Unwalla H RNA Biol. 2018; 15(3):327-337.

PMID: 29431588 PMC: 5927724. DOI: 10.1080/15476286.2017.1414131.


References
1.
Yi R, Qin Y, Macara I, Cullen B . Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003; 17(24):3011-6. PMC: 305252. DOI: 10.1101/gad.1158803. View

2.
Westerhout E, Ooms M, Vink M, Das A, Berkhout B . HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005; 33(2):796-804. PMC: 548362. DOI: 10.1093/nar/gki220. View

3.
Das A, Brummelkamp T, Westerhout E, Vink M, Madiredjo M, Bernards R . Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol. 2004; 78(5):2601-5. PMC: 369246. DOI: 10.1128/jvi.78.5.2601-2605.2004. View

4.
Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

5.
Leff S, Rosenfeld M, Evans R . Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem. 1986; 55:1091-117. DOI: 10.1146/annurev.bi.55.070186.005303. View